CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin
2021 · Cardio-Oncology · 13 citations
https://doi.org/10.1186/s40959-021-00103-0
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
651
Citations
12
h-index
13
i10-index
Adolfo Quiñones‐Lombraña is an academic researcher from Long Island University. The author has contributed to research in topics: Chemotherapy-induced cardiotoxicity and mitigation & Cardiovascular Function and Risk Factors & Aldose Reductase and Taurine. The author has an h-index of 12, co-authored 21 publications.
ORCID: 0000-0001-6935-2934Click to start Chat